Applied Molecular Transport is pleased to announce that Robert (Bob) Baughman, PharmD, PhD has joined the company as its Chief Development Officer. In this role, Dr. Baughman is leading the company’s product development activities with responsibility for all CMC, Technical Operations, Biological Sciences, Product Teams, and associated preclinical and translational science activities. With a rich and impactful career that has included advancing many programs to the clinic, and registration and launch of highly complex biological therapeutic products, Dr. Baughman brings to Applied Molecular Transport a wealth of expertise, knowledge and networks that are unique in the biopharmaceutical industry. With a focus on Immunology & Inflammation and Metabolic Diseases, Dr. Baughman and his growing team are propelling the company’s products through development and positioning a deep pipeline development capability for novel biopharmaceutical candidates generated by the company’s platform technologies.


 Click here to view Mr. Baughman's bio.